Target cell | Effects of type I IFNs |
NK cells | Increased cytolytic activity.135 |
CD4+ T cells | Prolonged survival, promotion of Th1/Th10 helper profile, increased IL-12R expression and generation of memory cells.136 137 |
CD8+ cytotoxic T cells | Enhanced cytotoxicity, inhibition of apoptosis.136 |
Regulatory T cells | Suppression of Treg activity.136 138 139 |
Th17 T cells | Skewing of Th cells towards T17 profile and IL-17 production.136 138 139 |
Macrophages | Enhanced intracellular killing of pathogens and expression of costimulatory molecules.135 |
Dendritic cells | Maturation, enhanced antigen presentation.136 |
pDCs | Enhanced type I IFN production, homing to lymph nodes.11 140 141 |
B cells | Increased plasma cell differentiation, isotype switch and enhanced antibody production, generation of memory cells and imprinting of ISG15 secretion in plasma cells.23 142 143 |
Neutrophils | Release of interferogenic oxidised mitochondrial DNA.46 |
Endothelial cells | Induction of apoptosis, impaired regeneration.144 145 |
Microglia | Synaptic pruning.146 |
IFN, interferon; IL, interleukin; NK, natural killer; pDC, plasmacytoid dendritic cell.